Psoriatic arthritis (PsA) develops in four stages ... possibly leading to permanent disability. Polyarticular PsA affects five or more joints, often in a symmetrical pattern, similar to rheumatoid ...

Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related ...

There have been seven approvals for polyarticular JIA, which is defined as JIA affecting five or more joints, while there have been six approvals for juvenile psoriatic arthritis. Systemic JIA ...

Clinical manifestations vary from a mild, slightly troublesome oligoarthritis to a severe, mutilating polyarticular form ... disease compared with rheumatoid arthritis. [13] Methodological ...

polyarticular juvenile idiopathic arthritis, psoriatic arthritis and ankylosing spondylitis. Two additional TNF blockers recently approved for the treatment of rheumatoid arthritis, golimumab and ...

In this edition, blue-collar workers more likely to miss work or quit due to psoriatic arthritis ... safety profile, in polyarticular-course juvenile idiopathic arthritis, according to data ...

Avtozma, which is Celltrion’s twelfth biosimilar to be approved by the EC, is a recombinant humanised monoclonal antibody designed to inhibit soluble and membrane-bound interleukin‑6 receptors ...

to evaluate if intravenous infusion affects signs and symptoms of oligoarticular or polyarticular juvenile idiopathic arthritis (JIA) and improve quality of life in suffering children aged 2 ...